Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (81-90 of 457) with videos related to

Pageof 46
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 17, 2021
Use of sublingual tacrolimus in adults undergoing hematopoietic cell transplant: A pilot studyHeather P May, Gabriel T Bartoo, Robert C Wolf, et al.
Blood|October 3, 2007
Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survivalMichelle A Elliott, Mark R Litzow, Louis L Letendre, et al.
Blood Advances|December 10, 2019
Inhibition of the mutated c-KIT kinase in AML1-ETO-positive leukemia cells restores sensitivity to PARP inhibitorMargaret Nieborowska-Skorska, Elisabeth M Paietta, Ross L Levine, et al.
Cell Research|October 10, 2018
A dynamic N<sup>6</sup>-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitorsFei Yan, Aref Al-Kali, Zijie Zhang, et al.
American Journal of Hematology|January 7, 2010
Phase1/-2 study of Pomalidomide in myelofibrosisRuben A Mesa, Animesh D Pardanani, Kebede Hussein, et al.
British Journal of Haematology|April 19, 2017
The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalitiesMark Gurney, Mrinal M Patnaik, Curtis A Hanson, et al.
British Journal of Haematology|August 14, 2008
Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphomaLuciano J Costa, Ivana N Micallef, David J Inwards, et al.
Clinical Lymphoma & Myeloma|April 28, 2006
Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myelomaDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.
Journal of Pain and Symptom Management|May 2, 2021
Perceptions of Hematology Among Palliative Care Physicians: Results of a Nationwide SurveyWil L Santivasi, Daniel S Childs, Kelly L Wu, et al.
Cancer|July 15, 2010
Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology GroupJacob M Rowe, Haesook T Kim, Peter A Cassileth, et al.
Pageof 46

Showing results (81-90 of 457) with videos related to

Sort By:
Pageof 46
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 17, 2021
Use of sublingual tacrolimus in adults undergoing hematopoietic cell transplant: A pilot studyHeather P May, Gabriel T Bartoo, Robert C Wolf, et al.
Blood|October 3, 2007
Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survivalMichelle A Elliott, Mark R Litzow, Louis L Letendre, et al.
Blood Advances|December 10, 2019
Inhibition of the mutated c-KIT kinase in AML1-ETO-positive leukemia cells restores sensitivity to PARP inhibitorMargaret Nieborowska-Skorska, Elisabeth M Paietta, Ross L Levine, et al.
Cell Research|October 10, 2018
A dynamic N<sup>6</sup>-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitorsFei Yan, Aref Al-Kali, Zijie Zhang, et al.
American Journal of Hematology|January 7, 2010
Phase1/-2 study of Pomalidomide in myelofibrosisRuben A Mesa, Animesh D Pardanani, Kebede Hussein, et al.
British Journal of Haematology|April 19, 2017
The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalitiesMark Gurney, Mrinal M Patnaik, Curtis A Hanson, et al.
British Journal of Haematology|August 14, 2008
Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphomaLuciano J Costa, Ivana N Micallef, David J Inwards, et al.
Clinical Lymphoma & Myeloma|April 28, 2006
Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myelomaDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.
Journal of Pain and Symptom Management|May 2, 2021
Perceptions of Hematology Among Palliative Care Physicians: Results of a Nationwide SurveyWil L Santivasi, Daniel S Childs, Kelly L Wu, et al.
Cancer|July 15, 2010
Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology GroupJacob M Rowe, Haesook T Kim, Peter A Cassileth, et al.
Pageof 46